These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


283 related items for PubMed ID: 7822812

  • 1. IL-12 reverses cytokine and immune abnormalities in Sezary syndrome.
    Rook AH, Kubin M, Cassin M, Vonderheid EC, Vowels BR, Wolfe JT, Wolf SF, Singh A, Trinchieri G, Lessin SR.
    J Immunol; 1995 Feb 01; 154(3):1491-8. PubMed ID: 7822812
    [Abstract] [Full Text] [Related]

  • 2. The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma.
    Rook AH, Kubin M, Fox FE, Niu Z, Cassin M, Vowels BR, Gottleib SL, Vonderheid EC, Lessin SR, Trinchieri G.
    Ann N Y Acad Sci; 1996 Oct 31; 795():310-8. PubMed ID: 8958942
    [Abstract] [Full Text] [Related]

  • 3. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ, Torosantucci A, Quinti I, Testa U, Peschle C, Cassone A.
    Cell Immunol; 1993 Dec 31; 152(2):530-43. PubMed ID: 8258154
    [Abstract] [Full Text] [Related]

  • 4. Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells.
    Vowels BR, Cassin M, Vonderheid EC, Rook AH.
    J Invest Dermatol; 1992 Jul 31; 99(1):90-4. PubMed ID: 1607682
    [Abstract] [Full Text] [Related]

  • 5. Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies.
    Tendler CL, Burton JD, Jaffe J, Danielpour D, Charley M, McCoy JP, Pittelkow MR, Waldmann TA.
    Cancer Res; 1994 Aug 15; 54(16):4430-5. PubMed ID: 7913876
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis.
    Rook AH, Gottlieb SL, Wolfe JT, Vowels BR, Sood SS, Niu Z, Lessin SR, Fox FE.
    Clin Exp Immunol; 1997 Jan 15; 107 Suppl 1():16-20. PubMed ID: 9020930
    [Abstract] [Full Text] [Related]

  • 7. In vitro responsiveness to IL-18 in combination with IL-12 or IL-2 by PBMC from patients with bronchial asthma and atopic dermatitis.
    El-Mezayen RE, Matsumoto T.
    Clin Immunol; 2004 Apr 15; 111(1):61-8. PubMed ID: 15093553
    [Abstract] [Full Text] [Related]

  • 8. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
    Andersson J, Skansén-Saphir U, Sparrelid E, Andersson U.
    Clin Exp Immunol; 1996 May 15; 104 Suppl 1():10-20. PubMed ID: 8625537
    [Abstract] [Full Text] [Related]

  • 9. Increased interleukin 5 production in eosinophilic Sézary syndrome: regulation by interferon alfa and interleukin 12.
    Suchin KR, Cassin M, Gottleib SL, Sood S, Cucchiara AJ, Vonderheid EC, Rook AH.
    J Am Acad Dermatol; 2001 Jan 15; 44(1):28-32. PubMed ID: 11148473
    [Abstract] [Full Text] [Related]

  • 10. IL-18-induced expression of intercellular adhesion molecule-1 in human monocytes: involvement in IL-12 and IFN-gamma production in PBMC.
    Yoshida A, Takahashi HK, Nishibori M, Iwagaki H, Yoshino T, Morichika T, Yokoyama M, Kondo E, Akagi T, Tanaka N.
    Cell Immunol; 2001 Jun 15; 210(2):106-15. PubMed ID: 11520077
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Su DL, Wang HJ, Ji XH, Li YY, Xuan HB, Heng C, Li YF.
    Acta Pharmacol Sin; 2006 Aug 15; 27(8):1051-7. PubMed ID: 16867258
    [Abstract] [Full Text] [Related]

  • 12. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
    Kobashi K, Iwagaki H, Yoshino T, Morimoto Y, Kohka H, Kodama M, Nishibori M, Akagi T, Tanaka N.
    Anticancer Res; 2001 Aug 15; 21(5):3285-93. PubMed ID: 11848485
    [Abstract] [Full Text] [Related]

  • 13. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha.
    Daftarian PM, Kumar A, Kryworuchko M, Diaz-Mitoma F.
    J Immunol; 1996 Jul 01; 157(1):12-20. PubMed ID: 8683105
    [Abstract] [Full Text] [Related]

  • 14. Butyrate differentially regulates cytokines and proliferation in porcine peripheral blood mononuclear cells.
    Weber TE, Kerr BJ.
    Vet Immunol Immunopathol; 2006 Sep 15; 113(1-2):139-47. PubMed ID: 16725211
    [Abstract] [Full Text] [Related]

  • 15. [Cytokines in children with immunodeficiencies].
    Kowalczyk D.
    Folia Med Cracov; 1999 Sep 15; 40(1-2):5-97. PubMed ID: 10909468
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM, Lima PG, Filho RG, Hygino J, Milczanowski SF, Andrade AF, Lauria C, Brindeiro R, Tanuri A, Bento CA.
    AIDS; 2007 Aug 20; 21(13):1763-70. PubMed ID: 17690575
    [Abstract] [Full Text] [Related]

  • 17. Peripheral blood mononuclear cells from autologous hematopoietic stem cell transplantation recipients produce and respond to IL-12.
    Guillaume T, Kubin M, Sekhavat M, Rubinstein DB, Trinchieri G, Symann M.
    Bone Marrow Transplant; 1996 Oct 20; 18(4):733-9. PubMed ID: 8899188
    [Abstract] [Full Text] [Related]

  • 18. An in vitro Shwartzman reaction-like response is augmented age-dependently in human peripheral blood mononuclear cells.
    Motegi A, Kinoshita M, Sato K, Shinomiya N, Ono S, Nonoyama S, Hiraide H, Seki S.
    J Leukoc Biol; 2006 Mar 20; 79(3):463-72. PubMed ID: 16387840
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma.
    Minty A, Ferrara P, Caput D.
    Eur Cytokine Netw; 1997 Jun 20; 8(2):189-201. PubMed ID: 9262968
    [Abstract] [Full Text] [Related]

  • 20. Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers.
    Zou JP, Morford LA, Chougnet C, Dix AR, Brooks AG, Torres N, Shuman JD, Coligan JE, Brooks WH, Roszman TL, Shearer GM.
    J Immunol; 1999 Apr 15; 162(8):4882-92. PubMed ID: 10202033
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.